 The monoclonal antibody ustekinumab appears to be a safe treatment option, and may help people with moderate to severe active Crohn's disease.The long term safety and effectiveness of monoclonal antibody treatment is not known.The monoclonal antibody briakinumab is not effective for people with active Crohn's disease and it is no longer being manufactured.